Untargeted Antifungal Treatment Strategies for Invasive Candidiasis in Non-neutropenic Critically Ill Patients: Current Evidence and Insights

Untargeted Antifungal Treatment Strategies for Invasive Candidiasis in Non-neutropenic Critically... Curr Fungal Infect Rep (2017) 11:84–91 DOI 10.1007/s12281-017-0288-3 CURRENT MANAGEMENT OF FUNGAL INFECTIONS (M MICELI, SECTION EDITOR) Untargeted Antifungal Treatment Strategies for Invasive Candidiasis in Non-neutropenic Critically Ill Patients: Current Evidence and Insights 1 1 1 Andrea Cortegiani & Vincenzo Russotto & Santi Maurizio Raineri & 1 2 1 Cesare Gregoretti & Francesco Giuseppe De Rosa & Antonino Giarratano Published online: 22 July 2017 Springer Science+Business Media, LLC 2017 . . Abstract Keywords Invasive candidiasis Invasive fungal infection . . . Purpose of Review The purpose of this study was to pro- Candida infection Candidemia Empiric treatment vide an overview and insights on important new concepts Antifungal treatment on untargeted antifungal treatment strategies, namely pro- phylaxis pre-emptive and empiric treatments for the man- agement of invasive candidiasis (IC) in non-neutropenic Introduction critically ill patients. Recent Findings Recently, clinical practice guidelines provid- Invasive candidiasis (IC) is a major cause of morbidity and ed recommendation for the management of IC. However, re- mortality in critically ill patients [1]. Critically ill patients have sults from recent trials and systematic reviews questioned the several risk factors for IC development such as broad- effect of untargeted antifungal treatment strategies, especially spectrum antibiotic treatment, disruption http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Current Fungal Infection Reports Springer Journals

Untargeted Antifungal Treatment Strategies for Invasive Candidiasis in Non-neutropenic Critically Ill Patients: Current Evidence and Insights

Loading next page...
 
/lp/springer_journal/untargeted-antifungal-treatment-strategies-for-invasive-candidiasis-in-BT5TkMtuZt
Publisher
Springer Journals
Copyright
Copyright © 2017 by Springer Science+Business Media, LLC
Subject
Medicine & Public Health; Infectious Diseases; Internal Medicine; Tropical Medicine; Occupational Medicine/Industrial Medicine; Pneumology/Respiratory System
ISSN
1936-3761
eISSN
1936-377X
D.O.I.
10.1007/s12281-017-0288-3
Publisher site
See Article on Publisher Site

Abstract

Curr Fungal Infect Rep (2017) 11:84–91 DOI 10.1007/s12281-017-0288-3 CURRENT MANAGEMENT OF FUNGAL INFECTIONS (M MICELI, SECTION EDITOR) Untargeted Antifungal Treatment Strategies for Invasive Candidiasis in Non-neutropenic Critically Ill Patients: Current Evidence and Insights 1 1 1 Andrea Cortegiani & Vincenzo Russotto & Santi Maurizio Raineri & 1 2 1 Cesare Gregoretti & Francesco Giuseppe De Rosa & Antonino Giarratano Published online: 22 July 2017 Springer Science+Business Media, LLC 2017 . . Abstract Keywords Invasive candidiasis Invasive fungal infection . . . Purpose of Review The purpose of this study was to pro- Candida infection Candidemia Empiric treatment vide an overview and insights on important new concepts Antifungal treatment on untargeted antifungal treatment strategies, namely pro- phylaxis pre-emptive and empiric treatments for the man- agement of invasive candidiasis (IC) in non-neutropenic Introduction critically ill patients. Recent Findings Recently, clinical practice guidelines provid- Invasive candidiasis (IC) is a major cause of morbidity and ed recommendation for the management of IC. However, re- mortality in critically ill patients [1]. Critically ill patients have sults from recent trials and systematic reviews questioned the several risk factors for IC development such as broad- effect of untargeted antifungal treatment strategies, especially spectrum antibiotic treatment, disruption

Journal

Current Fungal Infection ReportsSpringer Journals

Published: Jul 22, 2017

References

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Search

Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly

Organize

Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.

Access

Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

DeepDyve

Freelancer

DeepDyve

Pro

Price

FREE

$49/month
$360/year

Save searches from
Google Scholar,
PubMed

Create lists to
organize your research

Export lists, citations

Read DeepDyve articles

Abstract access only

Unlimited access to over
18 million full-text articles

Print

20 pages / month

PDF Discount

20% off